Comparison of the Efficacy of 2 Different Botulinum Toxin Injection Techniques in Gastrocnemius Muscle Spasticity in Hemiplegic Patients: A Randomized Double-Blind Controlled Study.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 39343047.
- Also identified by DOI 10.1016/j.apmr.2024.09.011.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To compare the efficacy of the innervation zone-targeted injection technique (EUROMUSCULUS/USPRM (Ultrasound Study Group of the International Society of Physical and Rehabilitation Medicine) spasticity approach) and the injection technique along the muscle length. A double-blind randomized controlled trial. Department of rehabilitation medicine of a medical center. One hundred patients with stroke experiencing ankle plantar flexor spasticity. In addition to conventional rehabilitation, eligible patients were randomly assigned to 2 groups. The experimental group was injected with botulinum toxin along the length of the muscle, whereas the control group was injected with the same dose and volume of botulinum toxin 25%-35% proximal to the medial head and 20%-30% proximal to the lateral aspect of the head of the gastrocnemius muscle. Modified Ashworth scale, modified Tardieu scale, ankle range of motion measurement, and 10-meter walk test were used before and 1 month after injection. The study was completed by 60 participants with a mean age of 59.96±12.15 years. Both injection methods were found to be effective on range of motion, spasticity level, ambulation, and walking speed. There was no statistically significant difference between injection methods. Both injection methods of botulinum toxin A produce similar clinical effects.
Medical subject headings
- Muscle Spasticity
- Hemiplegia
- Muscle, Skeletal
- Botulinum Toxins, Type A
- Neuromuscular Agents